Women Healthcare Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug (EVISTA, XGEVA, Prolia, Mirena, Zometa, Reclast/Aclasta, Minastrin 24 Fe, NuvaRing, FORTEO, Premarin, ACTONEL, ORTHO TRI-CY LO (28)), By Application (Hormonal Infertility, Postmenopausal Osteoporosis, Endometriosis, Contraceptives, Menopause, Polycystic Ovary Syndrome, Others), By Region and Competition, 2019-2029F

  • Industry : Healthcare
  • Pages : NA
  • Published Date : NA
Customization Enquiry

Buy Now

Summary

Report Description

Forecast Period

2025-2029

Market Size (2023)

USD 9.52 Billion

Market Size (2029)

USD 12.33 Billion

CAGR (2024-2029)

5.25%

Fastest Growing Segment

Prolia

Largest Market

North America

Market Overview

Global Women Healthcare Market was valued at USD 9.52 Billion in 2023 and is anticipated to project steady growth in the forecast period with a CAGR of 5.25% through 2029. The global women's healthcare market has witnessed significant growth and evolution in recent years, driven by a combination of factors such as increasing awareness, technological advancements, and a growing emphasis on women's health and well-being. As societies around the world continue to recognize the importance of prioritizing women's health, the women's healthcare market has become a focal point for innovation and investment.

Advances in technology have played a pivotal role in shaping the women's healthcare market. From telemedicine and digital health platforms to wearable devices and personalized medicine, technology has empowered women to take control of their health and well-being. Remote monitoring, virtual consultations, and health apps are becoming increasingly popular, providing convenient and accessible healthcare solutions. There is a growing emphasis on preventive healthcare, encouraging women to adopt healthier lifestyles and undergo regular screenings. Initiatives promoting early detection of diseases such as breast and cervical cancer have gained traction globally. The shift towards preventive care aims to reduce the burden of chronic conditions and improve overall health outcomes. Increased awareness of women's health issues has led to a more informed and proactive approach towards healthcare. Issues such as menstrual health, fertility, and menopause are now being discussed openly, challenging societal taboos and contributing to a more comprehensive understanding of women's healthcare needs.

Key Market Drivers

Changing Lifestyles and Nutrition are Driving the Global Women Healthcare Market.

The global women's healthcare market is undergoing a significant transformation, driven by changing lifestyles and a growing awareness of the critical role that nutrition plays in women's health. As societies evolve, so do the healthcare needs of women, prompting a surge in demand for innovative solutions and comprehensive care. The 21st century has witnessed a remarkable shift in the lifestyles of women worldwide. Factors such as increased urbanization, rising employment opportunities, and changing societal norms have led to alterations in daily routines and habits. While these changes bring new opportunities, they also present challenges to women's health. Sedentary lifestyles, stress, and inadequate sleep have become common features, contributing to various health issues. This shift has fueled a demand for healthcare solutions that address the specific needs of women in today's fast-paced world. Women are increasingly seeking healthcare services that provide holistic and personalized approaches to manage their health, taking into account their unique biological and lifestyle factors.

Nutrition is a cornerstone of overall health, and its significance is particularly pronounced in women's well-being. Proper nutrition is essential for the prevention of chronic diseases, the maintenance of a healthy weight, and the support of reproductive health. The global awareness of the intricate relationship between nutrition and women's health has led to a surge in demand for nutritional guidance, dietary supplements, and specialized healthcare products. The prevalence of conditions such as osteoporosis, anemia, and hormonal imbalances has led to a growing emphasis on nutrition as a preventive and therapeutic measure. Women are increasingly turning to healthcare providers and nutritionists for guidance on balanced diets, micronutrient supplementation, and lifestyle modifications that can positively impact their health.

The intersection of changing lifestyles and the focus on nutrition has created a dynamic landscape in the global women's healthcare market. Market players are responding to this shift by developing a wide array of products and services that cater to the unique healthcare needs of women. From fertility solutions and hormonal therapies to nutritionally fortified supplements and digital health platforms, the market is witnessing a surge in innovation. Moreover, the integration of technology, such as wearable devices and health apps, allows women to monitor and manage their health in real-time, empowering them to make informed decisions about their well-being. This convergence of healthcare and technology is reshaping the delivery of women's healthcare services, making them more accessible, personalized, and preventive.

Increasing Disposable Income is Driving the Global Women Healthcare Market

In recent years, a notable trend has emerged in the global healthcare sector – the surge in demand for women's healthcare services. This trend is closely linked to the increase in disposable income among women worldwide. As women gain greater financial independence, they are prioritizing their health and well-being, leading to a substantial growth in the global women's healthcare market. With higher disposable incomes, women have greater access to comprehensive reproductive health services. This includes advanced fertility treatments, family planning options, and prenatal care. As women are empowered to make choices regarding their reproductive health, the demand for specialized healthcare services in this domain has significantly increased.

Rising disposable incomes have enabled women to invest in preventive healthcare measures. Routine screenings, vaccinations, and health check-ups are now more affordable and accessible, leading to the early detection and prevention of various health conditions. This shift towards preventive care has positively impacted the overall well-being of women. The influx of disposable income has driven significant investments in research and development within the women's healthcare sector. This has resulted in technological advancements such as innovative diagnostic tools, minimally invasive surgical procedures, and personalized treatment plans. These developments enhance the overall quality of care for women. Women with higher disposable incomes are increasingly seeking holistic healthcare services that address both physical and mental well-being. This includes wellness programs, stress management, and mental health support tailored to the unique needs of women. As a result, the market for these services has expanded substantially. The aesthetic aspect of women's healthcare has also witnessed a surge in demand. Procedures such as cosmetic surgery, dermatological treatments, and other aesthetic interventions have become more accessible to women with increased disposable incomes. This reflects a broader societal shift towards self-care and personal grooming.


Download Free Sample Report

Key Market Challenges

Health Disparities

Health disparities among women remain a pervasive challenge in the global healthcare landscape. While advancements in medical science have led to significant improvements in women's health, a closer look reveals that not all women benefit equally. Disparities in healthcare access, treatment outcomes, and preventive care persist, posing a substantial hurdle to achieving comprehensive well-being for women worldwide. Health disparities refer to the differences in health outcomes and healthcare access among different populations. These differences are often influenced by various factors, including socioeconomic status, race, ethnicity, geographic location, education, and more. Unfortunately, these disparities are glaringly evident in the realm of women's healthcare, affecting everything from routine medical care to specialized treatments.

Key Market Trends 

Technological Advancements

In recent years, the healthcare industry has experienced a paradigm shift, with technological advancements playing a pivotal role in transforming the landscape of women's healthcare. The Global Women's Healthcare Market has been witnessing a surge in innovation, fueled by breakthroughs in medical technology, data analytics, and telehealth solutions. Technological advancements have ushered in an era of precision medicine, allowing healthcare providers to tailor treatment plans based on an individual's genetic makeup, lifestyle, and environmental factors. In women's healthcare, this approach is particularly beneficial for conditions such as breast and ovarian cancers. Genetic testing and personalized treatment options empower women to make informed decisions about their health, leading to more effective and targeted interventions.

The rise of telehealth has been a game-changer in women's healthcare, providing convenient and accessible options for consultations, monitoring, and follow-up care. Telehealth platforms enable women to connect with healthcare professionals from the comfort of their homes, overcoming geographical barriers and improving the overall patient experience. Remote monitoring devices, such as wearable sensors, allow continuous tracking of vital signs and other health metrics, facilitating early detection of potential issues. Advances in fertility treatments and reproductive health technologies have significantly expanded options for women planning to start a family. Assisted reproductive technologies, including in vitro fertilization (IVF) and preimplantation genetic testing (PGT), have become more sophisticated and effective. Additionally, digital health tools and apps help women track their menstrual cycles, ovulation, and fertility windows, empowering them to take charge of their reproductive health. There has been a surge in digital health platforms dedicated to women's wellness, covering a broad spectrum of health concerns from pregnancy and maternal care to menopause and beyond. These platforms provide evidence-based information, personalized advice, and community support, fostering a holistic approach to women's health. From mental health apps to nutrition and fitness trackers, digital tools are empowering women to proactively manage their well-being. Artificial intelligence (AI) and machine learning are revolutionizing diagnostics in women's healthcare. These technologies enhance the accuracy and efficiency of medical imaging, such as mammography and ultrasound, leading to early detection of conditions like breast cancer. AI algorithms also assist healthcare professionals in analyzing vast amounts of patient data, enabling more precise diagnoses and treatment recommendations.

Segmental Insights

Drug Insights

Based on the category of drug, prolia emerged as the dominant player in the global market for Women Healthcare in 2023. Prolia, also known as denosumab, is a monoclonal antibody designed to treat osteoporosis in postmenopausal women. Developed by Amgen, this cutting-edge medication is a RANK ligand (RANKL) inhibitor, disrupting the biological pathway responsible for bone resorption. By inhibiting RANKL, Prolia effectively reduces the risk of fractures and enhances bone density. Osteoporosis, characterized by weakened bones and an increased susceptibility to fractures, particularly affects postmenopausal women due to hormonal changes that occur during menopause. Prolia has emerged as a frontrunner in osteoporosis treatment, offering a novel approach to managing bone health. The global prevalence of osteoporosis has led to an increased demand for effective treatments, and Prolia has positioned itself as a go-to solution. Prolia's success in the market can be attributed to its clinical efficacy and safety profile. Numerous clinical trials have demonstrated its ability to significantly increase bone mineral density and reduce the risk of fractures in postmenopausal women. Additionally, its mode of action, targeting RANKL, provides a unique advantage over traditional osteoporosis treatments.

The convenience of Prolia is another factor contributing to its dominance. Unlike oral medications that require daily or weekly administration, Prolia is administered through a subcutaneous injection once every six months. This not only enhances patient compliance but also ensures a consistent and controlled dosage. Prolia's success is not limited to a specific region, as it has achieved widespread acceptance globally. The drug has secured regulatory approvals from health authorities in various countries, attesting to its safety and efficacy. The expanding market reach of Prolia has positioned it as a frontrunner in the global women's healthcare market, capturing the attention of healthcare professionals, patients, and investors alike.



Download Free Sample Report

Regional Insights

North America emerged as the dominant region in the global Women Healthcare market in 2023, holding the largest market share in terms of value. North America has been at the forefront of adopting and developing cutting-edge medical technologies. The integration of technology in healthcare has resulted in improved diagnostics, personalized treatment plans, and enhanced patient care. The region's continuous investment in research and development has led to the creation of innovative solutions for various women's health issues. The United States and Canada boast advanced healthcare infrastructures that provide comprehensive services for women across all stages of life. Accessible healthcare facilities, well-equipped hospitals, and specialized clinics contribute to the region's dominance in offering a wide array of women's healthcare services.

Recent Developments

  • In July 2023, Bayer revealed a significant collaboration with Peking University aimed at facilitating the shift from developing pharmaceutical research to advancing drug discovery and innovation. This partnership is expected to enhance scientific exploration of cutting-edge technologies across the pharmaceutical value chain in China. Additionally, this endeavor has the potential to create fresh opportunities for growth in the women's health sector.
  • In June 2023, Agile Therapeutics, Inc. disclosed a partnership with vitaCare Prescription Services aimed at broadening patient access and enhancing the efficiency of distributing the Twirla transdermal system. Twirla is an innovative contraceptive patch containing combined hormonal elements, designed for use by women capable of reproduction.

Key Market Players

  • Bayer AG
  • Cardinal Health
  • Allergan plc.
  • Merck & Co.
  • Pfizer Inc.
  • Amgen Inc.
  • Agile Therapeutics Inc.
  • Ferring Pharmaceuticals
  • Mylan N.V.
  • Lupin Limited
  • Blairex Laboratories
  • Apothecus Pharmaceutical

By Drug

By Application

By Region
  • EVISTA
  • XGEVA
  • Prolia
  • Mirena
  • Zometa
  • Reclast/Aclasta
  • Minastrin 24 Fe
  • NuvaRing
  • FORTEO
  • Premarin
  • ACTONEL
  • ORTHO TRI-CY LO (28)
  • Hormonal Infertility
  • Postmenopausal Osteoporosis
  • Endometriosis
  • Contraceptives
  • Menopause
  • Polycystic Ovary Syndrome
  • Others
  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa


Report Scope:

In this report, the Global Women Healthcare Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

  • Women Healthcare Market, By Drug:

o   EVISTA

o   XGEVA

o   Prolia

o   Mirena

o   Zometa

o   Reclast/Aclasta

o   Minastrin 24 Fe

o   NuvaRing

o   FORTEO

o   Premarin

o   ACTONEL

o   ORTHO TRI-CY LO (28)

  • Women Healthcare Market, By Application:

o   Hormonal Infertility

o   Postmenopausal Osteoporosis

o   Endometriosis

o   Contraceptives

o   Menopause

o   Polycystic Ovary Syndrome

o   Others

  • Women Healthcare Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  France

§  United Kingdom

§  Italy

§  Germany

§  Spain

o   Asia-Pacific

§  China

§  India

§  Japan

§  Australia

§  South Korea

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Women Healthcare Market.

Available Customizations:

Global Women Healthcare market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Global Women Healthcare Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]  

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.    Markets Covered

1.2.2.    Years Considered for Study

1.2.3.    Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Global Women Healthcare  Market Outlook

4.1.  Market Size & Forecast

4.1.1.    By Value

4.2.  Market Share & Forecast

4.2.1.    By Drug (EVISTA, XGEVA, Prolia, Mirena, Zometa, Reclast/Aclasta, Minastrin 24 Fe, NuvaRing, FORTEO, Premarin, ACTONEL, ORTHO TRI-CY LO (28))

4.2.2.    By Application (Hormonal Infertility, Postmenopausal Osteoporosis, Endometriosis, Contraceptives, Menopause, Polycystic Ovary Syndrome, Others)

4.2.3.    By Region

4.2.4.    By Company (2023)

4.3.  Market Map

4.3.1.    By Drug

4.3.2.    By Application

4.3.3.    By Region

5.    Asia Pacific Women Healthcare  Market Outlook

5.1.  Market Size & Forecast

5.1.1.    By Value

5.2.  Market Share & Forecast

5.2.1.    By Drug

5.2.2.    By Application

5.2.3.    By Country

5.3.  Asia Pacific: Country Analysis

5.3.1.    China Women Healthcare  Market Outlook

5.3.1.1.        Market Size & Forecast

5.3.1.1.1.           By Value

5.3.1.2.        Market Share & Forecast

5.3.1.2.1.           By Drug

5.3.1.2.2.           By Application

5.3.2.    India Women Healthcare  Market Outlook

5.3.2.1.        Market Size & Forecast

5.3.2.1.1.           By Value

5.3.2.2.        Market Share & Forecast

5.3.2.2.1.           By Drug

5.3.2.2.2.           By Application

5.3.3.    Australia Women Healthcare  Market Outlook

5.3.3.1.        Market Size & Forecast

5.3.3.1.1.           By Value

5.3.3.2.        Market Share & Forecast

5.3.3.2.1.           By Drug

5.3.3.2.2.           By Application

5.3.4.    Japan Women Healthcare  Market Outlook

5.3.4.1.        Market Size & Forecast

5.3.4.1.1.           By Value

5.3.4.2.        Market Share & Forecast

5.3.4.2.1.           By Drug

5.3.4.2.2.           By Application

5.3.5.    South Korea Women Healthcare  Market Outlook

5.3.5.1.        Market Size & Forecast

5.3.5.1.1.           By Value

5.3.5.2.        Market Share & Forecast

5.3.5.2.1.           By Drug

5.3.5.2.2.           By Application

6.    Europe Women Healthcare  Market Outlook

6.1.  Market Size & Forecast

6.1.1.    By Value

6.2.  Market Share & Forecast

6.2.1.    By Drug

6.2.2.    By Application

6.2.3.    By Country

6.3.  Europe: Country Analysis

6.3.1.    France Women Healthcare  Market Outlook

6.3.1.1.        Market Size & Forecast

6.3.1.1.1.           By Value

6.3.1.2.        Market Share & Forecast

6.3.1.2.1.           By Drug

6.3.1.2.2.           By Application

6.3.2.    Germany Women Healthcare  Market Outlook

6.3.2.1.        Market Size & Forecast

6.3.2.1.1.           By Value

6.3.2.2.        Market Share & Forecast

6.3.2.2.1.           By Drug

6.3.2.2.2.           By Application

6.3.3.    Spain Women Healthcare  Market Outlook

6.3.3.1.        Market Size & Forecast

6.3.3.1.1.           By Value

6.3.3.2.        Market Share & Forecast

6.3.3.2.1.           By Drug

6.3.3.2.2.           By Application

6.3.4.    Italy Women Healthcare  Market Outlook

6.3.4.1.        Market Size & Forecast

6.3.4.1.1.           By Value

6.3.4.2.        Market Share & Forecast

6.3.4.2.1.           By Drug

6.3.4.2.2.           By Application

6.3.5.    United Kingdom Women Healthcare  Market Outlook

6.3.5.1.        Market Size & Forecast

6.3.5.1.1.           By Value

6.3.5.2.        Market Share & Forecast

6.3.5.2.1.           By Drug

6.3.5.2.2.           By Application

7.    North America Women Healthcare  Market Outlook

7.1.  Market Size & Forecast

7.1.1.    By Value

7.2.  Market Share & Forecast

7.2.1.    By Drug

7.2.2.    By Application

7.2.3.    By Country

7.3.  North America: Country Analysis

7.3.1.    United States Women Healthcare  Market Outlook

7.3.1.1.        Market Size & Forecast

7.3.1.1.1.           By Value

7.3.1.2.        Market Share & Forecast

7.3.1.2.1.           By Drug

7.3.1.2.2.           By Application

7.3.2.    Mexico Women Healthcare  Market Outlook

7.3.2.1.        Market Size & Forecast

7.3.2.1.1.           By Value

7.3.2.2.        Market Share & Forecast

7.3.2.2.1.           By Drug

7.3.2.2.2.           By Application

7.3.3.    Canada Women Healthcare  Market Outlook

7.3.3.1.        Market Size & Forecast

7.3.3.1.1.           By Value

7.3.3.2.        Market Share & Forecast

7.3.3.2.1.           By Drug

7.3.3.2.2.           By Application

8.    South America Women Healthcare  Market Outlook

8.1.  Market Size & Forecast

8.1.1.    By Value

8.2.  Market Share & Forecast

8.2.1.    By Drug

8.2.2.    By Application

8.2.3.    By Country

8.3.  South America: Country Analysis

8.3.1.    Brazil Women Healthcare  Market Outlook

8.3.1.1.        Market Size & Forecast

8.3.1.1.1.           By Value

8.3.1.2.        Market Share & Forecast

8.3.1.2.1.           By Drug

8.3.1.2.2.           By Application

8.3.2.    Argentina Women Healthcare  Market Outlook

8.3.2.1.        Market Size & Forecast

8.3.2.1.1.           By Value

8.3.2.2.        Market Share & Forecast

8.3.2.2.1.           By Drug

8.3.2.2.2.           By Application

8.3.3.    Colombia Women Healthcare  Market Outlook

8.3.3.1.        Market Size & Forecast

8.3.3.1.1.           By Value

8.3.3.2.        Market Share & Forecast

8.3.3.2.1.           By Drug

8.3.3.2.2.           By Application

9.    Middle East and Africa Women Healthcare  Market Outlook

9.1.  Market Size & Forecast

9.1.1.    By Value

9.2.  Market Share & Forecast

9.2.1.    By Drug

9.2.2.    By Application

9.2.3.    By Country

9.3.  MEA: Country Analysis

9.3.1.    South Africa Women Healthcare  Market Outlook

9.3.1.1.        Market Size & Forecast

9.3.1.1.1.           By Value

9.3.1.2.        Market Share & Forecast

9.3.1.2.1.           By Drug

9.3.1.2.2.           By Application

9.3.2.    Saudi Arabia Women Healthcare  Market Outlook

9.3.2.1.        Market Size & Forecast

9.3.2.1.1.           By Value

9.3.2.2.        Market Share & Forecast

9.3.2.2.1.           By Drug

9.3.2.2.2.           By Application

9.3.3.    UAE Women Healthcare  Market Outlook

9.3.3.1.        Market Size & Forecast

9.3.3.1.1.           By Value

9.3.3.2.        Market Share & Forecast

9.3.3.2.1.           By Drug

9.3.3.2.2.           By Application

10. Market Dynamics

10.1.             Drivers

10.2.             Challenges

11. Market Trends & Developments

11.1.             Recent Developments

11.2.             Product Launches

11.3.             Mergers & Acquisitions

12. Global Women Healthcare  Market: SWOT Analysis

13. Porter’s Five Forces Analysis

13.1.             Competition in the Industry

13.2.             Potential of New Entrants

13.3.             Power of Suppliers

13.4.             Power of Customers

13.5.             Threat of Substitute Product 

14. Competitive Landscape

14.1.   Bayer AG

14.1.1.          Company Snapshot

14.1.2.          Product & Services

14.1.4.          Financials (In case of listed)

14.1.5.          Recent Developments

14.1.6.          SWOT Analysis

14.2.   Cardinal Health

14.3.   Allergan plc.

14.4.   Merck & Co.

14.5.   Pfizer Inc.

14.6.   Amgen Inc.

14.7.   Agile Therapeutics Inc.

14.8.   Ferring Pharmaceuticals

14.9.   Mylan N.V.

14.10.Lupin Limited

14.11.Blairex Laboratories

14.12.Apothecus Pharmaceutical

15. Strategic Recommendations

16. About Us & Disclaimer

Figures and Tables

Frequently asked questions

down-arrow

The market size of the Global Women Healthcare Market was estimated to be USD 9.52 Billion in 2023.

down-arrow

The Global Women Healthcare Market was analyzed for the historical period of 2019 to 2022. While the base year was 2023, estimation for the year 2024 was calculated and the market growth was further forecast for 2025 to 2029.

down-arrow

Bayer AG, Cardinal Health, Allergan plc., Merck & Co., Pfizer Inc., Amgen Inc., Agile Therapeutics Inc., Ferring Pharmaceuticals, Mylan N.V., Lupin Limited, Blairex Laboratories, Apothecus Pharmaceutical were the top players operating in the Global Women Healthcare Market in 2023.

down-arrow

Shifting dietary habits and lifestyles alongside rising disposable incomes are the major drivers for the Global Women Healthcare Market.

Related Reports

profile

Sakshi Bajaal

Business Consultant
Press Release

Women Healthcare Market to Grow with a CAGR of 5.25% through 2029

Jul, 2024

Changing lifestyles and nutrition and increasing disposable income are factors driving the Global Women Healthcare Market in the forecast period 2025-2029.

Why Choose Us